Verastem Inc. (VSTM)
VSTM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$7.45
-9.70% on the day
Market cap
$674.7M
Small cap
Revenue · 2025
$30.9M
+209.1% on 2024
Net income · 2025
-$209.5M
-677.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | VSTM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2012 |
| SEC CIK | 0001526119 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | MA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $30.9M |
| Net income | -$209.5M |
| Operating income | -$170.1M |
| Net margin | -677.6% |
| Operating margin | -550.3% |
| Revenue growth | +209.1% |
| Cash | $205.0M |
| Total assets | $246.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 21.8× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-11-17 |
| Latest annual report | 10-K | 2026-03-04 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report FORM 8-K | 8-K | 2026-10-14 |
| Latest proxy | DEF 14A | 2026-04-09 |
Source: SEC EDGAR submissions feed, 1,013 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.2% |
| 1 month | +4.6% |
| 3 months | +33.0% |
| Year to date | -0.6% |
| 1 year | -17.4% |
| From 52-week high | -27.9% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| IVA | Inventiva S.A. American Depository Shares | $2.87 | -8.01% | $678.1M |
| PHAR | Pharming Group N.V. ADS each representing 10 | $9.44 | -1.77% | $666.7M |
| COLL | Collegium Pharmaceutical Inc. | $21.53 | -2.36% | $700.9M |
| AVTX | Avalo Therapeutics Inc. | $12.01 | -9.29% | $644.1M |
| LXRX | Lexicon Pharmaceuticals Inc. | $1.61 | -2.42% | $716.4M |
| IMMX | Immix Biopharma Inc. | $8.69 | -6.05% | $720.4M |
| ABUS | Arbutus Biopharma Corporation | $4.11 | -0.96% | $630.0M |
| ANNX | Annexon Inc. | $3.83 | -3.28% | $726.1M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier